Sylvain Peuget

Years Active: 2019-2023
Publications (10 Years): 6

Karolinska Institutet Institutionen for Mikrobiologi Tumorbiologi och Cellbiologi

Aix-Marseille Université (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet Institutionen for Mikrobiologi Tumorbiologi och Cellbiologi Apr 01 2014

Sweden

Postdoctoral researcher

Centre de Recherche en Cancérologie de Marseille Aug 20 2008 - Feb 24 2013

France

PhD Student

Education History

Aix-Marseille Université Oct 01 2008 - Dec 13 2012

France

PHD

Aix-Marseille Université Oct 01 2007 - Sep 30 2008

France

MSC

Publications

Sylvain Peuget, Galina Selivanova
MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 Reactivation. Cancer discovery 13 (5) (2023)
Sylvain Peuget, Galina Selivanova
MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 Reactivation. Cancer discovery 13 (5) (2023)
Yue Zhan, Xiaolei Zhou, Sylvain Peuget, Madhurendra Singh, Brian D Peyser, Zhimin Fan, Galina Selivanova
Decreased DNA Damage and Improved p53 Specificity of RITA Analogs. Molecular cancer therapeutics 21 (10) (2022)
Marie-Stéphanie Aschtgen, Konstantinos Fragkoulis, Gema Sanz, Staffan Normark, Galina Selivanova, Birgitta Henriques-Normark, Sylvain Peuget
Enterobacteria impair host p53 tumor suppressor activity through mRNA destabilization. Oncogene 41 (15) (2022)
Jiawei Zhu, Madhurendra Singh, Galina Selivanova, Sylvain Peuget
Pifithrin-α alters p53 post-translational modifications pattern and differentially inhibits p53 target genes. Scientific reports 10 (1) (2020)
Johannes Ristau, Vincent van Hoef, Sylvain Peuget, Jiawei Zhu, Bo-Jhih Guan, Shuo Liang, Maria Hatzoglou, Ivan Topisirovic, Galina Selivanova, Ola Larsson
RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity. Cell death & disease 10 (11) (2019)

Sylvain Peuget.css-eqlu8i{font-size:small;padding-left:4px;}